By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Augmenix 

204 2nd Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236


SEARCH JOBS


Industry
Medical Device






Company News
Augmenix Release: Phase 3 Trial Data Show Use Of SpaceOAR Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment 2/24/2017 9:25:32 AM
Augmenix Release: Company Announces Positive Three-Year Long-Term Data Highlighting Benefits Of Spaceoar Hydrogel Spacer For Patients With Prostate Cancer 1/12/2017 9:53:45 AM
Augmenix Announces New Category 1 CPT Code From The American Medical Association For Periprostatic Implantation Of Biodegradable Material 11/9/2016 9:02:34 AM
Augmenix Announces Positive Spaceoar Clinical Trial Results Demonstrating Superior Outcomes At 3-Years 9/27/2016 10:51:38 AM
Augmenix Financing Will Enable Sales Growth 7/13/2016 10:49:00 AM
Augmenix Announces The Publication Of The Spaceoar Hydrogel Pivotal Clinical Study Results: Application Technique And Patient Tolerance In Men Undergoing Prostate Cancer Radiotherapy 3/31/2016 10:58:31 AM
Augmenix’ SpaceOAR System Experiences Rapid U.S. Adoption 10/15/2015 11:09:31 AM
Augmenix Announces Publication Of Spaceoar System Clinical Trial Results In Leading Radiation Oncology Journal 6/11/2015 8:51:19 AM
Augmenix Announces FDA Clearance Of SpaceOAR System 4/2/2015 9:02:04 AM
Massachusett's Augmenix $10.8 Million Series D 7/24/2014 6:53:24 AM
12
//-->